InsiderInsights.com Daily Round Up 2/8/16: CFR, ENH, AN, HEAR

|
Includes: ALXN, AN, ASFI, BDGE, CFR, CRM, EDIT, ENH, GOOG, HEAR, INVN, ITRI, LLY, MSFT, NFBK, RIT, RXN, SYK, VEEV, ZION
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 2/8/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history. Also feel free to email us with any questions on our proprietary insider data, Insider Filer Statistics, and Insider Company Ratings.

On Today's Tables:

Insider trades were rated Significant at :

  • Zions Bancorp (NASDAQ:ZION);
  • Veeva Systems (NYSE:VEEV);
  • Turtle Beach (NASDAQ:HEAR);
  • Endurance Spec (NYSE:ENH);
  • Cullen Frost Bankers (NYSE:CFR), and;
  • Autonation (NYSE:AN).

Insider trades were rated Nearly Significant at:

  • Invensense (NYSE:INVN), and;
  • Salesforce Com (NYSE:CRM).

Insider trades were considered Insignificant at:

  • Rexnord (NYSE:RXN);
  • Lmp Real Estate Income Fund (NYSE:RIT);
  • Itron (NASDAQ:ITRI);
  • Asta Funding (NASDAQ:ASFI);
  • Northfield Bancorp (NASDAQ:NFBK);
  • Microsoft (NASDAQ:MSFT);
  • Alphabet (NASDAQ:GOOG), and;
  • Alexion Pharm (NASDAQ:ALXN).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Stryker (NYSE:SYK);
  • Lilly Eli (NYSE:LLY), and;
  • Bridge Bancorp (NASDAQ:BDGE).

There is an IPO at:

  • Editas Medicine (NASDAQ:EDIT).

It's difficult to argue significance for most transactions made during IPOs.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Cascade Inv BO Autonation AN B $12,673,162
2 Charman John CB,CEO Endurance Spec ENH B $5,872,654
3 Scopia Capital Mgt BO Itron ITRI B $3,071,707
4 Sg Vtb BO Turtle Beach HEAR JB* $2,500,000
5 Quinn Stephen D DIR Zions Bancorp ZION JB* $2,181,090
6 Evans Richard W Jr CB,CEO Cullen Frost Bankers CFR B $1,957,200
7 Mangrove Partners Master Fund BO Asta Funding ASFI B $1,852,904
8 Flynn James E BO Editas Medicine EDIT JB* $1,600,000
9 Bulldog Investors General Partnership BO Lmp Real Estate Income Fund RIT B $448,166
10 Jones Paul W DIR Rexnord RXN B $342,918
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Gates William DIR Microsoft MSFT AS $154,489,184
2 Page Lawrence CEO,DIR,BO Alphabet GOOG AS $24,059,014
3 Sohn Young A BO Veeva Systems VEEV AS $3,193,726
4 Shah Amit DIR Invensense INVN S $2,602,326
5 Benioff Marc CB,CEO Salesforce Com CRM AS $2,250,370
6 Bell Leonard DIR Alexion Pharm ALXN S $2,215,483
7 Basswood Capital Mgt BO Bridge Bancorp BDGE S $1,575,622
8 Ryan Patrick Louis DIR Northfield Bancorp NFBK S $1,476,505
9 Fry Stephen F VP,HR Lilly Eli LLY S $1,201,190
10 Stryker Ronda E DIR Stryker SYK AS $1,162,111
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

If you're interested in the insider history of a stock not shown here, you can search by ticker.

Did you miss our Previous Daily Round Up?

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.